Phosphine

Phosphine

SCHEMBL2005915

P.c1ccc(-c2cccc(C34CC5CC(CC(C5)C3)C4)c2C23CC4CC(CC(C4)C2)C3)cc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 1/20 0.41
HSD11B1 P28845 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
CNR2 P34972 2/20 0.36
CNR1 P21554 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27676406 0.98 MEN1 (0.43) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL27694967 0.86 MEN1 (0.46) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL2005913 0.80 HTT (0.38) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL18582441 0.78 HSD11B1 (0.40) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL21038138 0.75 MEN1 (0.39) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL27628848 0.74 HTT (0.40) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL27676404 0.73 MEN1 (0.40) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL31253002 0.73 MEN1 (0.40) MEN1KMT2ANPSR1HTTHSD11B1
SCHEMBL27869456 0.72 HTT (0.43) HTTHSD11B1GRIN2DGRIN3BGRIN1
SCHEMBL21873616 0.72 LMNA (0.37) MEN1KMT2AHTTHSD11B1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964758-B2 Process for production of 2-(substituted phenyl)-3,3,3-trifluoropropene compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-21 US disclosed
US-20100160683-A1 Process for Production of 2-(Substituted Phenyl)-3,3,3-Trifluoropropene Compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160683-A1 Process for Production of 2-(Substituted Phenyl)-3,3,3-Trifluoropropene Compound PEX3, SCO2, LPO MEN1 1622/4885KMT2A 2764/4885NPSR1 3250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.